Skip to main content
Erschienen in: Diabetologia 8/2004

01.08.2004 | Article

Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk

Erschienen in: Diabetologia | Ausgabe 8/2004

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Fat accumulation in the liver has been shown to be closely correlated with hepatic insulin resistance and features of insulin resistance, also independently of body weight. It remains to be established how fat in the liver correlates with that in other depots, and whether any association differs between men and women.

Methods

Liver fat (assessed using proton spectroscopy), intra-abdominal and subcutaneous fat (measured using magnetic resonance imaging) and markers of insulin resistance, including serum adiponectin, were determined in 132 non-diabetic subjects: 66 men (age 41±1 years) and 66 women (age 42±1 years).

Results

Although the women had almost twice as much subcutaneous fat as the men (5045±207 vs 2610±144 cm3, p<0.0001), amounts of intra-abdominal fat (1305±80 vs 1552±111 cm3, NS) and liver fat (6.7±0.8 vs 8.9±1.2%, NS) were similar. In this study, no sex differences were observed with respect to serum insulin, adiponectin, triglyceride and HDL cholesterol concentrations. Of all measures of body composition, liver fat was best correlated with serum insulin (r=0.58, p<0.001), with no difference observed between men and women. Serum adiponectin was inversely correlated with liver fat content (r=−0.21, p<0.05). Multiple linear regression analysis revealed that intra-abdominal fat was significantly associated with liver fat, independently of serum adiponectin and subcutaneous fat. Liver fat, but not intra-abdominal fat, significantly explained the variation in serum insulin concentrations.

Conclusions/interpretation

Intra-abdominal fat is independently associated with liver fat, whereas subcutaneous fat is not. Liver fat, but not intra-abdominal fat, is independently associated with serum insulin. Men and women with similar amounts of intra-abdominal and liver fat do not exhibit sex differences in markers of insulin resistance (serum insulin, triglycerides, HDL cholesterol and adiponectin).
Literatur
1.
Zurück zum Zitat Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMed Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960–967PubMed
2.
Zurück zum Zitat Marceau P, Biron S, Hould FS et al. (1999) Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517CrossRefPubMed Marceau P, Biron S, Hould FS et al. (1999) Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84:1513–1517CrossRefPubMed
3.
Zurück zum Zitat Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850PubMed Marchesini G, Brizi M, Bianchi G et al. (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844–1850PubMed
4.
Zurück zum Zitat Hartz AJ, Rupley DC, Rimm AA (1984) The association of girth measurements with disease in 32,856 women. Am J Epidemiol 119:71–80PubMed Hartz AJ, Rupley DC, Rimm AA (1984) The association of girth measurements with disease in 32,856 women. Am J Epidemiol 119:71–80PubMed
5.
Zurück zum Zitat Landin K, Stigendal L, Eriksson E et al. (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044–1048CrossRefPubMed Landin K, Stigendal L, Eriksson E et al. (1990) Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism 39:1044–1048CrossRefPubMed
6.
Zurück zum Zitat Katzel LI, Busby-Whitehead MJ, Goldberg AP (1993) Adverse effects of abdominal obesity on lipoprotein lipids in healthy older men. Exp Gerontol 28:411–420CrossRefPubMed Katzel LI, Busby-Whitehead MJ, Goldberg AP (1993) Adverse effects of abdominal obesity on lipoprotein lipids in healthy older men. Exp Gerontol 28:411–420CrossRefPubMed
7.
Zurück zum Zitat Ohlson L-O, Larsson B, Svärdsudd K et al. (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men in 1913. Diabetes 34:1055–1058PubMed Ohlson L-O, Larsson B, Svärdsudd K et al. (1985) The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men in 1913. Diabetes 34:1055–1058PubMed
8.
Zurück zum Zitat Kaye SA, Folsom AR, Sprafka JM, Prineas RJ, Wallace RB (1991) Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 44:329–334CrossRefPubMed Kaye SA, Folsom AR, Sprafka JM, Prineas RJ, Wallace RB (1991) Increased incidence of diabetes mellitus in relation to abdominal adiposity in older women. J Clin Epidemiol 44:329–334CrossRefPubMed
9.
Zurück zum Zitat Casassus P, Fontbonne A, Thibult N et al. (1992) Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arterioscler Thromb 12:1387–1392PubMed Casassus P, Fontbonne A, Thibult N et al. (1992) Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arterioscler Thromb 12:1387–1392PubMed
10.
Zurück zum Zitat Frayn KN (2000) Visceral fat and insulin resistance—causative or correlative? Br J Nutr 83 [Suppl 1]:S71–S77 Frayn KN (2000) Visceral fat and insulin resistance—causative or correlative? Br J Nutr 83 [Suppl 1]:S71–S77
11.
Zurück zum Zitat Reitman ML, Arioglu E, Gavrilova O, Taylor SI (2000) Lipoatrophy revisited. Trends Endocrinol Metab 11:410–416CrossRefPubMed Reitman ML, Arioglu E, Gavrilova O, Taylor SI (2000) Lipoatrophy revisited. Trends Endocrinol Metab 11:410–416CrossRefPubMed
12.
Zurück zum Zitat Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456–8460CrossRefPubMed Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI (2000) Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456–8460CrossRefPubMed
13.
Zurück zum Zitat Gavrilova O, Marcus-Samuels B, Graham D et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271–278PubMed Gavrilova O, Marcus-Samuels B, Graham D et al. (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271–278PubMed
14.
Zurück zum Zitat Vozarova B, Stefan N, Lindsay RS et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889–1895PubMed Vozarova B, Stefan N, Lindsay RS et al. (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51:1889–1895PubMed
15.
Zurück zum Zitat Sutinen J, Häkkinen AM, Westerbacka J et al. (2002) Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 16:2183–2193CrossRefPubMed Sutinen J, Häkkinen AM, Westerbacka J et al. (2002) Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 16:2183–2193CrossRefPubMed
16.
Zurück zum Zitat Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023–3028CrossRefPubMed
17.
Zurück zum Zitat Tiikkainen M, Tamminen M, Häkkinen AM et al. (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867PubMed Tiikkainen M, Tamminen M, Häkkinen AM et al. (2002) Liver-fat accumulation and insulin resistance in obese women with previous gestational diabetes. Obes Res 10:859–867PubMed
18.
Zurück zum Zitat Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946CrossRefPubMed Yamauchi T, Kamon J, Waki H et al. (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7:941–946CrossRefPubMed
19.
Zurück zum Zitat Yu JG, Javorschi S, Hevener AL et al. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968–2974PubMed Yu JG, Javorschi S, Hevener AL et al. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968–2974PubMed
20.
Zurück zum Zitat Menzaghi C, Ercolino T, Di Paola R et al. (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306–2312PubMed Menzaghi C, Ercolino T, Di Paola R et al. (2002) A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51:2306–2312PubMed
21.
Zurück zum Zitat Hara K, Boutin P, Mori Y et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536–540PubMed Hara K, Boutin P, Mori Y et al. (2002) Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536–540PubMed
22.
Zurück zum Zitat Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495CrossRefPubMed Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O (1994) Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487–495CrossRefPubMed
23.
Zurück zum Zitat Ryysy L, Häkkinen AM, Goto T et al. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749–758PubMed Ryysy L, Häkkinen AM, Goto T et al. (2000) Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749–758PubMed
24.
Zurück zum Zitat Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810–817PubMed Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI (1985) Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810–817PubMed
25.
Zurück zum Zitat Marti B, Tuomilehto J, Salomaa V, Kartovaara L, Korhonen HJ, Pietinen P (1991) Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health 45:131–137PubMed Marti B, Tuomilehto J, Salomaa V, Kartovaara L, Korhonen HJ, Pietinen P (1991) Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health 45:131–137PubMed
26.
Zurück zum Zitat Kadish AH, Little RL, Sternberg JC (1968) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116–131 Kadish AH, Little RL, Sternberg JC (1968) A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin Chem 14:116–131
27.
Zurück zum Zitat Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22–29PubMed Kuzuya H, Blix PM, Horwitz DL, Steiner DF, Rubenstein AH (1977) Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes 26:22–29PubMed
28.
Zurück zum Zitat Stenman U-H, Pesonen K, Ylinen K, Huhtala ML, Teramo K (1984) Rapid chromatographic quantitation of glycosylated haemoglobins. J Chromatogr 297:327–332CrossRefPubMed Stenman U-H, Pesonen K, Ylinen K, Huhtala ML, Teramo K (1984) Rapid chromatographic quantitation of glycosylated haemoglobins. J Chromatogr 297:327–332CrossRefPubMed
29.
Zurück zum Zitat Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
30.
Zurück zum Zitat Wonnacott TH, Wonnacott RJ (1977) Tests for randomness—Runs test. In: Wonnacott TH, Wonnacott RJ (eds) Introductory statistics. Wiley, New York, pp 486–488 Wonnacott TH, Wonnacott RJ (1977) Tests for randomness—Runs test. In: Wonnacott TH, Wonnacott RJ (eds) Introductory statistics. Wiley, New York, pp 486–488
31.
Zurück zum Zitat Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4:20–34PubMed Vague J (1956) The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 4:20–34PubMed
32.
Zurück zum Zitat Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F (1986) Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44:739–746PubMed Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F (1986) Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 44:739–746PubMed
33.
Zurück zum Zitat Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G (1996) Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 144:335–345PubMed Schreiner PJ, Terry JG, Evans GW, Hinson WH, Crouse JR, Heiss G (1996) Sex-specific associations of magnetic resonance imaging-derived intra-abdominal and subcutaneous fat areas with conventional anthropometric indices. The Atherosclerosis Risk in Communities Study. Am J Epidemiol 144:335–345PubMed
34.
Zurück zum Zitat Cnop M, Landchild MJ, Vidal J et al. (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005–1015PubMed Cnop M, Landchild MJ, Vidal J et al. (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51:1005–1015PubMed
35.
Zurück zum Zitat Bertrais S, Balkau B, Vol S et al. (1999) Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women’s healthier cardiovascular risk profile. The D.E.S.I.R. Study. Int J Obes Relat Metab Disord 23:1085–1094CrossRefPubMed Bertrais S, Balkau B, Vol S et al. (1999) Relationships between abdominal body fat distribution and cardiovascular risk factors: an explanation for women’s healthier cardiovascular risk profile. The D.E.S.I.R. Study. Int J Obes Relat Metab Disord 23:1085–1094CrossRefPubMed
36.
Zurück zum Zitat Grauer WO, Moss AA, Cann CE, Goldberg HI (1984) Quantification of body fat distribution in the abdomen using computed tomography. Am J Clin Nutr 39:631–637PubMed Grauer WO, Moss AA, Cann CE, Goldberg HI (1984) Quantification of body fat distribution in the abdomen using computed tomography. Am J Clin Nutr 39:631–637PubMed
37.
Zurück zum Zitat Freedman DS, Jacobsen SJ, Barboriak JJ et al. (1990) Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 81:1498–1506PubMed Freedman DS, Jacobsen SJ, Barboriak JJ et al. (1990) Body fat distribution and male/female differences in lipids and lipoproteins. Circulation 81:1498–1506PubMed
38.
Zurück zum Zitat Lyu LC, Shieh MJ, Bailey SM et al. (1994) Relationship of body fat distribution with cardiovascular risk factors in healthy Chinese. Ann Epidemiol 4:434–444PubMed Lyu LC, Shieh MJ, Bailey SM et al. (1994) Relationship of body fat distribution with cardiovascular risk factors in healthy Chinese. Ann Epidemiol 4:434–444PubMed
39.
Zurück zum Zitat Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ (1996) Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633–638PubMed Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ (1996) Abdominal fat and insulin resistance in normal and overweight women: Direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM. Diabetes 45:633–638PubMed
40.
Zurück zum Zitat Colman E, Toth MJ, Katzel LI, Fonong T, Gardner AW, Poehlman ET (1995) Body fatness and waist circumference are independent predictors of the age-associated increase in fasting insulin levels in healthy men and women. Int J Obes Relat Metab Disord 19:798–803PubMed Colman E, Toth MJ, Katzel LI, Fonong T, Gardner AW, Poehlman ET (1995) Body fatness and waist circumference are independent predictors of the age-associated increase in fasting insulin levels in healthy men and women. Int J Obes Relat Metab Disord 19:798–803PubMed
41.
Zurück zum Zitat Lemieux S, Despres JP, Moorjani S et al. (1994) Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37:757–764CrossRefPubMed Lemieux S, Despres JP, Moorjani S et al. (1994) Are gender differences in cardiovascular disease risk factors explained by the level of visceral adipose tissue? Diabetologia 37:757–764CrossRefPubMed
42.
Zurück zum Zitat Pouliot MC, Despres JP, Lemieux S et al. (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460–468CrossRefPubMed Pouliot MC, Despres JP, Lemieux S et al. (1994) Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73:460–468CrossRefPubMed
43.
Zurück zum Zitat Ross R, Aru J, Freeman J, Hudson R, Janssen I (2002) Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282:E657–E663PubMed Ross R, Aru J, Freeman J, Hudson R, Janssen I (2002) Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282:E657–E663PubMed
44.
Zurück zum Zitat Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R (2003) Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284:E1065–E1071PubMed Nguyen-Duy TB, Nichaman MZ, Church TS, Blair SN, Ross R (2003) Visceral fat and liver fat are independent predictors of metabolic risk factors in men. Am J Physiol Endocrinol Metab 284:E1065–E1071PubMed
45.
Zurück zum Zitat Larsson B, Bengtsson C, Bjorntorp P et al. (1992) Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 135:266–273PubMed Larsson B, Bengtsson C, Bjorntorp P et al. (1992) Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Goteborg, Sweden. Am J Epidemiol 135:266–273PubMed
46.
Zurück zum Zitat Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG (1995) Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19:846–850PubMed Banerji MA, Buckley MC, Chaiken RL, Gordon D, Lebovitz HE, Kral JG (1995) Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 19:846–850PubMed
47.
Zurück zum Zitat Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906–E916PubMed Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC (2003) Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab 285:E906–E916PubMed
48.
Zurück zum Zitat Goto T, Onuma T, Takebe K, Kral JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841–845PubMed Goto T, Onuma T, Takebe K, Kral JG (1995) The influence of fatty liver on insulin clearance and insulin resistance in non-diabetic Japanese subjects. Int J Obes Relat Metab Disord 19:841–845PubMed
49.
Zurück zum Zitat Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV (1970) Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49:2017–2035PubMed Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV (1970) Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49:2017–2035PubMed
50.
Zurück zum Zitat Martin ML, Jensen MD (1991) Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88:609–613PubMed Martin ML, Jensen MD (1991) Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88:609–613PubMed
51.
Zurück zum Zitat Guo Z, Hensrud DD, Johnson CM, Jensen MD (1999) Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586–1592PubMed Guo Z, Hensrud DD, Johnson CM, Jensen MD (1999) Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586–1592PubMed
52.
Zurück zum Zitat Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847–850CrossRefPubMed Fried SK, Bunkin DA, Greenberg AS (1998) Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83:847–850CrossRefPubMed
53.
Zurück zum Zitat Van HV, Elizalde M, Ariapart P et al. (2000) The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 24:673–678CrossRefPubMed Van HV, Elizalde M, Ariapart P et al. (2000) The association of human adipose angiotensinogen gene expression with abdominal fat distribution in obesity. Int J Obes Relat Metab Disord 24:673–678CrossRefPubMed
54.
Zurück zum Zitat Dusserre E, Moulin P, Vidal H (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500:88–96CrossRefPubMed Dusserre E, Moulin P, Vidal H (2000) Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues. Biochim Biophys Acta 1500:88–96CrossRefPubMed
55.
Zurück zum Zitat Gabrielsson BG, Johansson JM, Lonn M et al. (2003) High expression of complement components in omental adipose tissue in obese men. Obes Res 11:699–708PubMed Gabrielsson BG, Johansson JM, Lonn M et al. (2003) High expression of complement components in omental adipose tissue in obese men. Obes Res 11:699–708PubMed
56.
Zurück zum Zitat Montague CT, Prins JB, Sanders L et al. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384–1391PubMed Montague CT, Prins JB, Sanders L et al. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47:1384–1391PubMed
57.
Zurück zum Zitat Niesler CU, Prins JB, O’Rahilly S, Siddle K, Montague CT (2001) Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNF-α. Int J Obes Relat Metab Disord 25:1027–1033CrossRefPubMed Niesler CU, Prins JB, O’Rahilly S, Siddle K, Montague CT (2001) Adipose depot-specific expression of cIAP2 in human preadipocytes and modulation of expression by serum factors and TNF-α. Int J Obes Relat Metab Disord 25:1027–1033CrossRefPubMed
58.
Zurück zum Zitat Rebuffe-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson JA, Bjorntorp P (1990) Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215–1219PubMed Rebuffe-Scrive M, Bronnegard M, Nilsson A, Eldh J, Gustafsson JA, Bjorntorp P (1990) Steroid hormone receptors in human adipose tissues. J Clin Endocrinol Metab 71:1215–1219PubMed
59.
Zurück zum Zitat Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN (2002) Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 51:2684–2690PubMed Evans K, Burdge GC, Wootton SA, Clark ML, Frayn KN (2002) Regulation of dietary fatty acid entrapment in subcutaneous adipose tissue and skeletal muscle. Diabetes 51:2684–2690PubMed
60.
Zurück zum Zitat Hultin M, Savonen R, Olivecrona T (1996) Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J Lipid Res 37:1022–1036PubMed Hultin M, Savonen R, Olivecrona T (1996) Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling. J Lipid Res 37:1022–1036PubMed
61.
Zurück zum Zitat Tiikkainen M, Bergholm R, Vehkavaara S et al. (2003) Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701–707PubMed Tiikkainen M, Bergholm R, Vehkavaara S et al. (2003) Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 52:701–707PubMed
62.
Zurück zum Zitat Duee PH, Pegorier JP, el Manoubi L, Herbin C, Kohl C, Girard J (1985) Hepatic triglyceride hydrolysis and development of ketogenesis in rabbits. Am J Physiol 249:E478–E484PubMed Duee PH, Pegorier JP, el Manoubi L, Herbin C, Kohl C, Girard J (1985) Hepatic triglyceride hydrolysis and development of ketogenesis in rabbits. Am J Physiol 249:E478–E484PubMed
63.
Zurück zum Zitat Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121:710–723PubMed Reid AE (2001) Nonalcoholic steatohepatitis. Gastroenterology 121:710–723PubMed
64.
Zurück zum Zitat Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83CrossRefPubMed Arita Y, Kihara S, Ouchi N et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83CrossRefPubMed
65.
Zurück zum Zitat Weyer C, Funahashi T, Tanaka S et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRefPubMed Weyer C, Funahashi T, Tanaka S et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930–1935CrossRefPubMed
66.
Zurück zum Zitat Sutinen J, Korsheninnikova E, Funahashi T, Matsuzawa Y, Nyman T, Yki-Jarvinen H (2003) Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab 88:1907–1910CrossRefPubMed Sutinen J, Korsheninnikova E, Funahashi T, Matsuzawa Y, Nyman T, Yki-Jarvinen H (2003) Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy. J Clin Endocrinol Metab 88:1907–1910CrossRefPubMed
67.
Zurück zum Zitat Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100CrossRefPubMed Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ (2003) The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91–100CrossRefPubMed
68.
Zurück zum Zitat Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953CrossRefPubMed
69.
Zurück zum Zitat Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881CrossRefPubMed
70.
Zurück zum Zitat Yamauchi T, Kamon J, Minokoshi Y et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295CrossRefPubMed Yamauchi T, Kamon J, Minokoshi Y et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295CrossRefPubMed
71.
Zurück zum Zitat Shand BI, Scott RS, Elder PA, George PM (2003) Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 5:349–353CrossRefPubMed Shand BI, Scott RS, Elder PA, George PM (2003) Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes Metab 5:349–353CrossRefPubMed
72.
Zurück zum Zitat Waki H, Yamauchi T, Kamon J et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363CrossRefPubMed Waki H, Yamauchi T, Kamon J et al. (2003) Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin. J Biol Chem 278:40352–40363CrossRefPubMed
Metadaten
Titel
Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk
Publikationsdatum
01.08.2004
Erschienen in
Diabetologia / Ausgabe 8/2004
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1460-1

Weitere Artikel der Ausgabe 8/2004

Diabetologia 8/2004 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.